‘Death on the Nile’ Tops Box Office Over Slow Super Bowl Weekend
(Bloomberg) -- “Death on the Nile” bumped “Jackass Forever” from the top of the domestic box office over a slow weekend when Americans were more focused on the Super Bowl.
The picture, from Walt Disney Co.'s 20th Century Studios, generated $12.9 million in U.S. and Canadian ticket sales, according to data from Comscore Inc. That trailed a forecast of $14.5 million from researcher Boxoffice Pro. The movie took in less than half the $28.7 million that its predecessor, 2017's “Murder on the Orient Express,” generated in its opening weekend five years ago.
“Jackass Forever,” from ViacomCBS Inc.'s Paramount Pictures, fell to second place with $8.1 million in domestic box office receipts in its sophomore weekend.
Key Insights
- “Death on the Nile” returns Kenneth Branagh to the role of Agatha Christie's Belgian detective Hercule Poirot. Branagh directed the film, which also features Gal Gadot, Armie Hammer, Letitia Wright and Russell Brand. About 65% of critics recommended it on review aggregator site Rotten Tomatoes.
- The film likely appeals to an older audience that has tended to stay away from theaters during the pandemic. “Jackass Forever,” on the other hand, targets a younger audience that may have been distracted this weekend by the build-up to Sunday's Super Bowl.
- Two other pictures made their debuts this week. “Marry Me,” a romantic comedy starring Jennifer Lopez and Owen Wilson from Comcast Corp.'s Universal Pictures, looked to get out ahead of Valentine's Day. “Blacklight” is an action-thriller distributed by independent Briarcliff Entertainment. It stars Liam Neeson.
Get More
See the schedule for upcoming releases.
©2022 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.